v3.26.1
SEGMENT INFORMATION (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Segment Reporting [Abstract]          
Clinical trials and other payments to R&D-related service providers $ 1,538 $ 442 $ 2,429 $ 598  
R&D payroll and related expenses, other than share-based compensation 511 485 774 854  
R&D share-based compensation expense 100 0 230 0  
G&A payroll and related expenses, other than share-based compensation 420 407 661 739  
G&A share-based compensation expenses 97 37 312 58  
Professional services 788 586 1,571 1,111  
Depreciation expenses 3 3 5 7  
Other segment expenses [1] 223 324 447 567  
Operating loss 3,680 2,284 6,429 3,934  
Interest income (14) (44) (46) (46)  
Interest expense 0 0 0 11  
Other financing expense (income), net (115) 260 (99) 336  
Income taxes [2] 3 3  
Net loss 3,551 2,503 6,284 4,238  
Segment assets 4,246 5,797 4,246 5,797 $ 7,215
Expenditures for segment assets 0 0 0 (7)  
Segment liabilities $ 4,202 $ 5,677 $ 4,202 $ 5,677 $ 4,612
[1] Other segment expenses include mainly general and administrative-related expenses, such as office lease expenses and maintenance and HR expenses.
[2] Represents an amount less than $1